Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.

W A Bleyer; P F Coccia; H N Sather; C Level; J Lukens; D J Niebrugge; S Siegel; P S Littman; S L Leikin; D R Miller

doi:10.1200/JCO.1983.1.5.317

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.

Identifier:nobleid.org/w1/20260515/FD203B7F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD203B7F.svg?ark=w1%2F20260515%2FFD203B7F)](https://nobleid.org/work/w1/20260515/FD203B7F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.

Identifier:nobleid.org/w1/20260515/FD203B7F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD203B7F.svg?ark=w1%2F20260515%2FFD203B7F)](https://nobleid.org/work/w1/20260515/FD203B7F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work